Fundz

NRG Therapeutics Appoints Claus Sundgreen as Chief Medical Officer

PRIVATEAug 03, 2026

Position

Chief Medical Officer

Company

NRG Therapeutics

Claus Sundgreen
StevenageBiotechnologyHealth CareTherapeutics

Description

NRG Therapeutics Ltd. has announced the appointment of Claus Sundgreen, M.D., as Chief Medical Officer, effective August 1, 2026. Dr

Who to call at NRG Therapeutics, and when

A new leader at NRG Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day NRG Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at NRG Therapeutics, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

NRG Therapeutics

Location

Stevenage, England, United Kingdom

About

NRG Therapeutics is a neuroscience drug discovery company building a pipeline of disease-modifying mitochondrial therapeutics to slow or halt the progression of neurodegenerative disorders such as Parkinson's and Amyotrophic Lateral Sclerosis (ALS), also known as motor neurone disease (MND).

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment NRG Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Neil
Likely contact at this company
••••••••@••••••••

See Neil's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for NRG Therapeutics's next move

Learn about Strategic plan

NRG Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.